AMSF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amerisafe Inc (AMSF) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near resistance with an overbought short-term setup, and there is no strong proprietary buy signal today. While sentiment from options leans mildly bullish and analysts are still mixed-to-positive, the latest analyst actions show downward price target revisions after an earnings miss. My direct view: wait rather than buy now.
AMSF is in a short-term upward trend, but the setup looks stretched. MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 is 85.825, which is deeply overbought and suggests the stock may be extended. Moving averages are converging, showing the trend is not strongly established yet. Price at 34.99 is near resistance levels at R1 34.61 and R2 35.559, with pivot at 33.075. The stock has a modeled probability of modest upside over the next day/week/month, but the current technical picture does not offer an attractive low-risk long-term entry.
["MACD is positive and expanding, supporting current momentum.", "Options open interest put-call ratio of 0.39 indicates bullish positioning.", "Analyst Citizens still maintains an Outperform rating.", "The company experienced no large claims in the first quarter, which is supportive for underwriting results.", "CEO confidence on sustaining top-line growth is a positive fundamental tone.", "Modeled short-term pattern suggests modest upside over the next day, week, and month."]
["RSI is extremely overbought at 85.825.", "Price is close to resistance, limiting near-term upside from current levels.", "Truist lowered its price target to $34 from $36 after the Q1 earnings miss and keeps only a Hold rating.", "Citizens also cut its target to $45 from $50, reflecting sector pressure and reserve concerns.", "No recent news catalyst in the past week.", "No strong AI Stock Picker or SwingMax signal today.", "Hedge funds and insiders are neutral with no significant buying trend.", "No recent congress trading data available."]
No usable latest-quarter financial snapshot was provided due to a data error, so I cannot assess revenue, earnings, or margin trends directly. The only quarter-specific information in the dataset is that Q1 included no large claims, but the company still missed earnings, which led to analyst target cuts. Based on that limited quarter context, operating performance appears mixed rather than strongly accelerating.
Analyst sentiment is mixed. Truist lowered its target to $34 from $36 and kept a Hold rating after the Q1 earnings miss, which is a cautious tone. Citizens lowered its target to $45 from $50 but kept an Outperform rating, citing lighter catastrophe losses but also continued concern about casualty reserve issues and broader P&C pricing pressure. Overall Wall Street view is split: some still see upside, but recent target cuts and the earnings miss weaken the bullish case.
